These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28577953)

  • 21. Completion pneumonectomy in patients with cancer: postoperative survival and mortality factors.
    Tabutin M; Couraud S; Guibert B; Mulsant P; Souquet PJ; Tronc F
    J Thorac Oncol; 2012 Oct; 7(10):1556-62. PubMed ID: 22982656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
    Ferguson MK; Vigneswaran WT
    Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
    Thorsteinsson H; Alexandersson A; Oskarsdottir GN; Skuladottir R; Isaksson HJ; Jonsson S; Gudbjartsson T
    J Thorac Oncol; 2012 Jul; 7(7):1164-9. PubMed ID: 22592213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer†.
    Nagata M; Ito H; Matsuzaki T; Furumoto H; Isaka T; Nishii T; Yokose T; Nakayama H
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1164-1170. PubMed ID: 28199511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute interstitial pneumonia following surgery for primary lung cancer.
    Muraoka M; Tagawa T; Akamine S; Oka T; Tsuchiya T; Araki M; Hayashi T; Nagayasu T
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):657-62. PubMed ID: 16893654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [10-year survival after lung resection for lung cancer].
    Krasnik M; Høier-Madsen K; Sparup J
    Ugeskr Laeger; 1994 Dec; 156(49):7357-60. PubMed ID: 7801397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumonectomy for non-small cell lung cancer: outcomes analysis.
    Kalathiya RJ; Saha SP
    South Med J; 2012 Jul; 105(7):350-4. PubMed ID: 22766661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity.
    Myrdal G; Gustafsson G; Lambe M; Hörte LG; Ståhle E
    Eur J Cardiothorac Surg; 2001 Oct; 20(4):694-9. PubMed ID: 11574210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors for lung injury after lung cancer resection.
    Alam N; Park BJ; Wilton A; Seshan VE; Bains MS; Downey RJ; Flores RM; Rizk N; Rusch VW; Amar D
    Ann Thorac Surg; 2007 Oct; 84(4):1085-91; discussion 1091. PubMed ID: 17888952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels.
    Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Thorac Cardiovasc Surg; 2005 Oct; 53(5):300-4. PubMed ID: 16208617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality.
    Bernard A; Deschamps C; Allen MS; Miller DL; Trastek VF; Jenkins GD; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1076-82. PubMed ID: 11385374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy.
    Pastorino U; Morelli D; Leuzzi G; Rolli L; Suatoni P; Taverna F; Bertocchi E; Boeri M; Sozzi G; Cantarutti A; Corrao G; Gronchi A
    Ann Surg Oncol; 2019 Mar; 26(3):869-875. PubMed ID: 30607764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative serum C-reactive protein levels in non-small cell lung cancer patients.
    Hara M; Yonei A; Ayabe T; Tomita M; Nakamura K; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2010 Apr; 16(2):85-90. PubMed ID: 20930660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sleeve resection for lung cancer: a report of 82 cases].
    Chen PC; Zhou XM; Chen QX; Liu JS; Yan FL; Jiang YH
    Ai Zheng; 2008 May; 27(5):510-5. PubMed ID: 18479601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of pulmonary resection for lung cancer in Norway, patients older than 70 years.
    Rostad H; Naalsund A; Strand TE; Jacobsen R; Talleraas O; Norstein J
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):325-8. PubMed ID: 15691690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.
    Pastorino U; Morelli D; Leuzzi G; Gisabella M; Suatoni P; Taverna F; Bertocchi E; Boeri M; Sozzi G; Cantarutti A; Corrao G
    Eur J Cancer; 2017 Jul; 79():90-97. PubMed ID: 28472743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of surgery in the treatment of lung cancer: their relationship with the extent of resection and preoperative respiratory function tests.
    Motta G; Ratto GB
    Acta Chir Belg; 1989; 89(3):161-5. PubMed ID: 2552720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bronchoplastic procedures for the resection of malignant bronchial neoplasms].
    Hollaus PH; Wurnig PN; Pridun NS
    Chirurg; 2002 Nov; 73(11):1115-22. PubMed ID: 12430063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lobectomy with pulmonary artery resection: morbidity, mortality, and long-term survival.
    Alifano M; Cusumano G; Strano S; Magdeleinat P; Bobbio A; Giraud F; Lebeau B; Régnard JF
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1400-5. PubMed ID: 19464456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.